Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00413881 · ClinicalTrials.gov registry record · NA
A Prospective Comparison of Alcon LADARVision Wavefront-guided LASIK Enhancement and Conventional LASIK Enhancement for the Correction of Residual Refractive Errors Following LASIK Procedures
A NA study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00413881: Completed NA study, sponsored by Walter Reed Army Medical Center.
NCT00413881 is a NA study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00413881, a NA study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a prospective clinical trial to compare conventional and WFG LASIK for enhancements on post-LASIK patients. Differences in safety, efficacy, visual quality, and refractive stability will also be compared during this study.
Interventions
- PROCEDURE WAVEFRONT- GUIDED LASIK ENHANCEMENT
- PROCEDURE CONVENTIONAL LASIK ENHANCEMENT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-03 |
| Phase | NA |
What the finished NCT00413881 record still lists
NCT00413881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which WAVEFRONT- GUIDED LASIK ENHANCEMENT is the first listed.
NCT00413881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00413881 about?
NCT00413881 is a clinical study titled "A Prospective Comparison of Alcon LADARVision Wavefront-guided LASIK Enhancement and Conventional LASIK Enhancement for the Correction of Residual Refractive Errors Following LASIK Procedures". The purpose of this study is to conduct a prospective clinical trial to compare conventional and WFG LASIK for enhancements on post-LASIK patients. Differences in safety, efficacy, visual quality, and refractive stability will also be compared during this study.
What is the current status of trial NCT00413881?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2004-07. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00413881?
The interventions under investigation include: WAVEFRONT- GUIDED LASIK ENHANCEMENT (PROCEDURE), CONVENTIONAL LASIK ENHANCEMENT (PROCEDURE).
Who is sponsoring clinical trial NCT00413881?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00413881's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia